Payal D. Parikh

Payal D. Parikh


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Erin McDonnellErin McDonnell
Erin McDonnell
Nicole AltomareNicole Altomare
Nicole Altomare
Yesha ParekhYesha Parekh
Yesha Parekh
RGRam C. Gowda
Ram C. Gowda
PPPayal D. Parikh
Payal D. Parikh
MBMartin Blaser
Martin Blaser
Coronavirus 2019 (COVID-19) has been reported to trigger Guillain–Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here we describe a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient’s episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. We also consider the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, we recommend close observation for neurologic symptoms over the next days and weeks.

21 July 2020 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MRMishal Reja
Mishal Reja
JNJay Naik
Jay Naik
PPPayal D. Parikh
Payal D. Parikh
Author(s): Reja, Mishal; Naik, Jay; Parikh, Payal

23 April 2025 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
PPPayal D. Parikh
Payal D. Parikh
PJPriya Jaisinghani
Priya Jaisinghani
SKSrivarsha Kaloth
Srivarsha Kaloth
AKAnagha Konakanchi
Anagha Konakanchi
NYNaveena Yanamala
Naveena Yanamala
SKSarang Kim
Sarang Kim
Background: Safe transitions of care post inpatient hospitalization require robust communication practices during the discharge process to ensure patient understanding. Objective: To determine if physician-led patient communication, inclusive of written and verbal instructions with the teach-back method, improves patient understanding of hospitalization and post-discharge needs. Design: This pre-post study was piloted at an urban, 600-bed, academic tertiary care hospital over a 3-month period. Participants: Study participants included adult patients admitted to the hospitalist medical teaching service (MTS). Intervention: Study participants received both a written summary and verbal instruction reinforced with teach-back method. The instruction included the four core domains of patient education: reason for admission, inpatient management, medication changes, and follow-up plan. Main Measures: Changes in mean patient understandings scores from pre- to post-intervention were evaluated on a 3-point scale (no, partial, or full understanding) in addition to basic demographics, level of schooling, and primary language spoken to better ascertain the drivers of improved health literacy. Key Results: Among 120 study participants, mean survey scores in all four testing domains showed improvement in patient understanding of “admitting diagnosis” (21.5%, 95% CI, 0.21 to 0.40; P < 0.0001), “treatment undergone” (35.1%, 95% CI, 0.34 to 0.58; P < 0.0001), “medication changes” (45.8%, 95% CI, 0.40 to 0.67; P < 0.0001), and “discharge follow-up” (38.1%, 95% CI, 0.39 to 0.63; P < 0.0001). Mean scores improved more in patients with lower levels of schooling in all testing domains, except for “understanding of medication changes,” showing more improvement in patients with high education achievement (95% CI, 0.08 to 1.09; P = 0.027). Conclusions: While standard discharge practice involves only a printed discharge packet, the use of a written summary of instructions and verbal reinforcement using teach-back methods improves patient understanding and health literacy of post-discharge needs during transitions of care.

13 June 2025 in Journal for Healthcare Quality
Verified
Journal Article
Open access
TNThomas A. Nahass
Thomas A. Nahass
PPPayal D. Parikh
Payal D. Parikh
CGChristopher Gilligan
Christopher Gilligan
SOStephen O'MAhony
Stephen O'MAhony
MLMichael L. Loftus
Michael L. Loftus
KGKenneth M. Granet
Kenneth M. Granet
Introduction: Hurricane Helene's disruption of Baxter's North Carolina manufacturing facility in September 2024 created significant supply disruptions and an urgent need to reduce intravenous fluid (IVF) usage across our 12 acute care hospital health system. Methods: Our approach combined an integrated informatics and operational response that included real-time electronic health record monitoring, clinical decision support tools, and hospital-level operational interventions. Results: We achieved and sustained a peak 44% reduction in IVF usage while maintaining quality metrics. Conclusions: Analysis of 68,430 patient encounters demonstrated no significant changes in acute kidney injury or mortality rate, although demonstrating a reduction in length of stay. This study describes the rationale and impact of our approach and provides a framework for healthcare systems facing similar supply chain disruptions.

4 November 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
BAByron Avihai
Byron Avihai
ESErin P. Sundel
Erin P. Sundel
ELEileen Lee
Eileen Lee
PGPatricia J. Greenberg
Patricia J. Greenberg
BCBrennan P. Cook
Brennan P. Cook
MBMartin Blaser
Martin Blaser
Elevated C-reactive protein (CRP) levels have been associated with poorer COVID-19 outcomes. While baseline CRP levels are higher in women, obese individuals, and older adults, the relationship between CRP, sex, body mass index (BMI), age, and COVID-19 outcomes remains unknown. To investigate, we performed a retrospective analysis on 824 adult patients with COVID-19 admitted during the first pandemic wave, of whom 183 (22.2%) died. The maximum CRP value over the first five hospitalization days better predicted hospitalization outcome than the CRP level at admission, as a maximum CRP > 10 mg/dL independently quadrupled the risk of death (p < 0.001). Males (p < 0.001) and patients with a higher BMI (p = 0.001) had higher maximum CRP values, yet CRP levels did not impact their hospitalization outcome. While CRP levels did not statistically mediate any relation between sex, age, or BMI with clinical outcomes, age impacted the association between BMI and the risk of death. For patients 60 or over, a BMI < 25 kg/m2 increased the risk of death (p = 0.017), whereas the reverse was true for patients <60 (p = 0.030). Further impact of age on the association between BMI, CRP, and the risk of death could not be assessed due to a lack of statistical power but should be further investigated.

31 October 2023 in mBio
Verified
Journal Article
Open access
DNDavid Natanov
David Natanov
BAByron Avihai
Byron Avihai
EMErin McDonnell
Erin McDonnell
ELEileen Lee
Eileen Lee
BCBrennan Cook
Brennan Cook
MBMartin Blaser
Martin Blaser
Predicting which patients are at greatest risk of severe disease from COVID-19 has the potential to improve patient outcomes and improve resource allocation. We developed machine learning models for predicting COVID-19 prognosis from a retrospective chart review of 969 hospitalized COVID-19 patients at Robert Wood Johnson University Hospital during the first pandemic wave in the United States, focusing on 77 variables from patients’ first day of hospital admission. Our best 77-variable model was better able to predict mortality (receiver operating characteristic area under the curve [ROC AUC] = 0.808) than CURB-65, a commonly used clinical prediction rule for pneumonia severity (ROC AUC = 0.722). After identifying highly predictive variables in our full models using Sh apley a dditive ex p lanations values, we generated two models, platelet count, lactate, age, blood urea nitrogen, aspartate aminotransferase, and C-reactive protein (PLABAC) and platelet count, red blood cell distribution width, age, blood urea nitrogen, lactate, and eosinophil count (PRABLE), that use age and five common laboratory tests to predict mortality (PLABAC: ROC AUC = 0.796, PRABLE: ROC AUC = 0.793), which also outperformed CURB-65. We externally validated PLABAC using data from the National COVID Cohort Collaborative Data Enclave from 7901 hospitalized COVID-19 patients from the pre-vaccination period and 1547 from the vaccination period, yielding ROC AUCs of 0.755 and 0.766, respectively. This study demonstrates that our models can accurately predict COVID-19 outcomes from a small number of variables obtained early in a patient’s hospital stay in patients from institutions around the United States after the initial pandemic wave. These models can serve as a clinical prediction aid and accurately capture a patient’s prognosis using a small number of routinely obtained laboratory values. IMPORTANCE: COVID-19 remains the fourth leading cause of death in the United States. Predicting COVID-19 patient prognosis is essential to help efficiently allocate resources, including ventilators and intensive care unit beds, particularly when hospital systems are strained. Our PLABAC and PRABLE models are unique because they accurately assess a COVID-19 patient’s risk of death from only age and five commonly ordered laboratory tests. This simple design is important because it allows these models to be used by clinicians to rapidly assess a patient’s risk of decompensation and serve as a real-time aid when discussing difficult, life-altering decisions for patients. Our models have also shown generalizability to external populations across the United States. In short, these models are practical, efficient tools to assess and communicate COVID-19 prognosis.